Skip to main content
Equibles

MORGAN STANLEY

Position in GNLX — GENELUX Corp

CIK 895421 NEW YORK, NY
Back to GNLX Full portfolio

Position in GNLX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$251,463
+$38,389 QoQ
Shares Held
83,543
-5.1% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 72 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 10% Shared 0% None 90%

Common Shares in GNLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. GNLX ranks #315 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in GNLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $251,463 83,543
2026-03-31 $213,074 88,048
2025-12-31 $401,943 92,189
2025-09-30 $254,703 60,644
2025-06-30 $162,181 56,510
2025-03-31 $186,326 69,010
2024-12-31 $127,062 53,840
2024-09-30 $70,919 29,924
2024-06-30 $173,918 89,191
2024-03-31 $381,540 59,338
2023-12-31 $867,342 61,909
2023-09-30 $732,322 29,903
2023-06-30 $122,992 3,759
2023-03-31 $55,036 1,984